Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nanami Ito

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cancer Diagnosis & Prognosis|July 4, 2024
Cachexia Index Is a Prognostic Indicator in Patients With Metastatic Urothelial Carcinoma Treated With Systemic ChemotherapyYoshihisa Mimura, Taku Naiki, Yosuke Sugiyama, et al.
Nature Plants|August 1, 2022
Two-step regulation of centromere distribution by condensin II and the nuclear envelope proteinsTakuya Sakamoto, Yuki Sakamoto, Stefan Grob, et al.
The Journal of Pathology|August 7, 2023
Fibrinogen Aα-chain amyloidosis outbreaks in Japanese squirrels (Sciurus lis): a potential disease modelSusumu Iwaide, Nanami Ito, Shiori Ogino, et al.
Anticancer Research|March 27, 2026
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving PembrolizumabYosuke Sugiyama, Taku Naiki, Toshiharu Morikawa, et al.
In Vivo (Athens, Greece)|June 27, 2025
Effect of Pembrolizumab on Lymph Node Dissection in Patients Who Experienced Bladder Cancer Recurrence Following Radical CystectomyYoshihiko Tasaki, Takashi Nagai, Taku Naiki, et al.
Communications Biology|January 23, 2023
Genomic analysis of an ultrasmall freshwater green alga, Medakamo hakooShoichi Kato, Osami Misumi, Shinichiro Maruyama, et al.
Asia-Pacific Journal of Clinical Oncology|April 29, 2024
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patientsYoshihiko Tasaki, Nanami Ito, Yoshihisa Mimura, et al.
Cancer Medicine|November 21, 2023
Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary studyYoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancer Diagnosis & Prognosis|July 4, 2024
Cachexia Index Is a Prognostic Indicator in Patients With Metastatic Urothelial Carcinoma Treated With Systemic ChemotherapyYoshihisa Mimura, Taku Naiki, Yosuke Sugiyama, et al.
Nature Plants|August 1, 2022
Two-step regulation of centromere distribution by condensin II and the nuclear envelope proteinsTakuya Sakamoto, Yuki Sakamoto, Stefan Grob, et al.
The Journal of Pathology|August 7, 2023
Fibrinogen Aα-chain amyloidosis outbreaks in Japanese squirrels (Sciurus lis): a potential disease modelSusumu Iwaide, Nanami Ito, Shiori Ogino, et al.
Anticancer Research|March 27, 2026
Prognostic Impact of Early GNRI Sustainability in Metastatic Urothelial Carcinoma Receiving PembrolizumabYosuke Sugiyama, Taku Naiki, Toshiharu Morikawa, et al.
In Vivo (Athens, Greece)|June 27, 2025
Effect of Pembrolizumab on Lymph Node Dissection in Patients Who Experienced Bladder Cancer Recurrence Following Radical CystectomyYoshihiko Tasaki, Takashi Nagai, Taku Naiki, et al.
Communications Biology|January 23, 2023
Genomic analysis of an ultrasmall freshwater green alga, Medakamo hakooShoichi Kato, Osami Misumi, Shinichiro Maruyama, et al.
Asia-Pacific Journal of Clinical Oncology|April 29, 2024
Real-world data on efficacy/safety and economic impact of nivolumab administered every 2 and 4 weeks among Japanese patientsYoshihiko Tasaki, Nanami Ito, Yoshihisa Mimura, et al.
Cancer Medicine|November 21, 2023
Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary studyYoshihiko Tasaki, Yosuke Sugiyama, Shuzo Hamamoto, et al.
Pageof 2